JENNIFER KNIPS: Open Payments
NPI 1093185670 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 28 payments from 14 companies in 2025. Trend: 2023 $615 · 2024 $805 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $135 |
| UCB, Inc. | 4 | $87 |
| Neurelis, Inc. | 5 | $82 |
| ACADIA Pharmaceuticals Inc | 5 | $75 |
| Integra LifeSciences Corporation | 1 | $30 |
| ARGENX US, INC. | 1 | $27 |
| Lilly USA, LLC | 1 | $23 |
| Globus Medical, Inc. | 1 | $23 |
| GENZYME CORPORATION | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
Products named: HYQVIA, VALTOCO, NUPLAZID, Zilbrysq, CODMAN CERTAS, VYVGART HYTRULO, Briviact, KISUNLA.
Industry payments across FL — which companies pay providers there.
